Výsledky vyhledávání - "Claudio, Iannacone"

Dexamethasone/Netilmicin Eye Drops and Eye Gel for the Treatment of Ocular Inflammation After Micro-Incisional Vitreoretinal Surgery

Autor: Stanislao Rizzo, Francesco Faraldi, Roberto Ratiglia, Claudio Iannacone, Paola Vaona, Vincenzo Papa, Antonio Rapisarda, Paolo Arpa, Paolo Maria Fantaguzzi

Publikováno v: Clinical Ophthalmology. 14:3297-3303

Purpose To evaluate the effect of dexamethasone/netilmicin (dexa/net) fixed combination in the treatment of ocular inflammation after sutureless micro-incisional vitreoretinal surgery (MIVS). Patients and Methods This multicenter, open, randomized, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::495c942bd61c6c222224f560d783f5be
https://doi.org/10.2147/opth.s257541

Zobrazit plný text záznamu

Plný text ve formátu HTML

Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial

Autor: Silvia Bonanno, Riccardo Giossi, Riccardo Zanin, Valentina Porcelli, Claudio Iannacone, Giovanni Baranello, Gary Ingenito, Stanley Iyadurai, Zorica Stevic, Stojan Peric, Lorenzo Maggi

Publikováno v: Journal of neurology. 269(11)

Spinal muscular atrophy (SMA) is an autosomal recessive disease where a deficient amount of SMN protein leads to progressive lower motor neuron degeneration. SMN-enhancing therapies are now available. Yet, fatigue and signs of impaired neuromuscular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37cabb275b2d4cfc0fa15a9ae2bb8b3a
https://pubmed.ncbi.nlm.nih.gov/35763114

Zobrazit plný text záznamu

Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update

Autor: Lorenzo Dottorini, Sara Pusceddu, Laura Catena, Giandomenico Di Menna, Anna Maria Marte, Emilio Bajetta, Italo Sarno, Francesca Spada, Claudio Iannacone

Publikováno v: Neuroendocrinology. 106:307-311

Background: We previously presented data of this multicentric, phase II study showing that everolimus plus octreotide long-acting repeatable (LAR) for advanced neuroendocrine neoplasms (NENs), in the first line setting, is an active and safe treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da31ec3433e908b6c441eff41f76e17
https://doi.org/10.1159/000479587

Zobrazit plný text záznamu

Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY study

Autor: Stefania Gori, Katia Cagossi, Giancarlo Bisagni, Claudio Iannacone, Claudio Zamagni, Paolo Morandi, Luca Gianni, Alba A. Brandes, Milvia Zambetti, Carmelo Bengala, Filippo Montemurro, Alessia Stell

Publikováno v: European journal of cancer (Oxford, England : 1990). 105

Background Subcutaneous trastuzumab (H SC) is a valuable alternative to the intravenous formulation. This study assessed H SC safety and tolerability in human epidermal growth factor receptor 2 (HER2)+ early/locally advanced breast cancer (EBC/LABC).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea58cbfedea33614c08e75b5baaafcaa
https://pubmed.ncbi.nlm.nih.gov/30396014

Zobrazit plný text záznamu

Effect of Aging, Glucose Level, and HIV Viral Load on Response to Treatment with Pegylated Interferon Plus Ribavirin in HIV/HCV Co-Infected Women

Autor: Paola Nasta, Giampiero Carosi, Massimo Puoti, Gabriella Verucchi, Ivana Maida, E. Angeli, Emanuele Pontali, Claudio Iannacone, Anna Maria Cattelan, Mariarosaria Giralda, Antonietta Caputo

Publikováno v: Journal of Women's Health. 24:159-164

BACKGROUND: This was a post-hoc analysis of the Optimized Pegylated interferons Efficacy and anti-Retroviral Approach (OPERA) study, originally designed to document routine clinical and treatment data in HIV/HCV coinfected patients treated with pegyl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69df9bb4bed710a3b0f765ec7fdb7325
https://doi.org/10.1089/jwh.2014.4796

Zobrazit plný text záznamu

Opera: Use of Pegylated Interferon plus Ribavirin for Treating HCV–HIV Coinfection in Interferon-Naive Patients

Autor: Amedeo Capetti, Gioacchino Angarano, Giampiero Carosi, Claudio Iannacone, Ivana Maida, Roberto Gulminetti, Paola Nasta, E. Raise, Raffaele Bruno, Massimo Puoti, Massimo Galli, Gabriella Verucchi, Antonietta Caputo, Veronica Ravasio, Emanuele Pontali, Giuseppe Cariti

Publikováno v: Antiviral Therapy. 19:735-745

Background The Optimized Pegylated interferons Efficacy and anti-Retroviral Approach (OPERA) study aimed to assess the efficacy and safety profile of treatment with pegylated interferons (PEG-IFNs) in interferon-naive patients with chronic HCV and HI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78042ac59c61b2677d2f4c3d21554c48
https://doi.org/10.3851/imp2757

Zobrazit plný text záznamu

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study

Autor: Claudio Iannacone, Laurence D’Agay, Edouard Louis, Silvio Danese, Geert R. D'Haens, Iris Dotan, Laurent Peyrin-Biroulet, Axel Dignass, Gerhard Rogler, Ailsa Hart

Publikováno v: BMJ open gastroenterology, 3(1). BMJ Publishing Group
BMJ Open Gastroenterology
BMJ Open Gastroenterology, BMJ Publishing Group, 2016, 3 (1), ⟨10.1136/bmjgast-2016-000092⟩

Introduction A study has been developed to assess the use and effectiveness of budesonide MMX for mild-to-moderate active ulcerative colitis (UC) in routine clinical practice. Methods and analysis A prospective, multicentre, observational, cohort stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::defda3855c5d0fab90a65b42a5cd496a
https://pure.amc.nl/en/publications/effectiveness-of-budesonide-mmx-cortiment-for-the-treatment-of-mildtomoderate-active-ulcerative-colitis-study-protocol-for-a-prospective-multicentre-observational-cohort-study(7ea8f5c9-672f-4712-941f-4a35f1a433f0).html

Zobrazit plný text záznamu

Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study

Autor: Anna Linda Zignego, Giacomo Laffi, J. Ranieri, Claudio Iannacone, Barbara Boldrini, Alessia Piluso, Elisa Fognani, Umberto Arena, Cristina Stasi, Laura Gragnani, Monica Monti, Alessio Fabbrizzi, T. Urraro

Publikováno v: Hepatology (Baltimore, Md.). 61(4)

Limited data are available about the efficacy of antiviral treatment in hepatitis C virus (HCV)–associated mixed cryoglobulinemia (MC), especially concerning the long-term effects of HCV eradication. The aim of this study was to evaluate the influe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f1ad6e8f5c011b7cc4c8c1f60d8213
https://pubmed.ncbi.nlm.nih.gov/25431357

Zobrazit plný text záznamu

OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy

Autor: Raffaele Bruno, Paola Nasta, Massimo Puoti, Amedeo Capetti, E. Raise, Massimo Galli, Claudio Iannacone, Giuseppe Cariti, G. Palmieri, Veronica Ravasio

Publikováno v: Liver international : official journal of the International Association for the Study of the Liver. 35(1)

Background & Aims Hepatitis C virus (HCV) genotype 3 (G3) is common among HIV/HCV co-infected individuals and associated with moderate sustained virological response (SVR) rates with pegylated interferon (PEG-IFN) plus ribavirin (RBV) therapy, while

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d13085fdb4ea1194bd1ad1380c59f71a
https://pubmed.ncbi.nlm.nih.gov/25041136

Zobrazit plný text záznamu

Real-world outcomes in patients with chronic hepatitis C: primary results of the PROBE study

Autor: Antonio Ascione, Barbara Deodato, Claudio Iannacone, Alessia Ciancio, Felice Piccinino, Caterina Golotta, Antonio Craxì

Publikováno v: European journal of gastroenterologyhepatology. 26(4)

BACKGROUND This large prospective multicentre cohort study aimed to improve knowledge of therapy for chronic hepatitis C (CHC) in real clinical practice. METHODS A diverse population of adults with CHC including patients with comorbid conditions, lab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e5b8a9fa4ba7ab8cc75e176a489c2c1
https://pubmed.ncbi.nlm.nih.gov/24569819

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání